Daniel Darlington, Ph.D.

Co-Founder and CSO

  • Dr. Darlington is a Research Physiologist at the US Army Institute of Surgical Research Fort Sam Houston, Texas and has spent a significant portion of his scientific career researching hemorrhagic shock treatments.

  • He has significant research experience and has held teaching positions at The University of California (San Francisco), University of Maryland, and Johns Hopkins.

  • Dr. Darlington worked in and ran Dr. Gann's lab for ~30 years leading up to their discovery.

  • He is a member of the editorial board for the journal, Shock.

  • Dr. Darlington received his B.S. from Pennsylvania State University and went on to receive his Ph.D. in Physiology from the University of Virginia.

  • He completed his Post-Doctoral Fellowship at University of California, San Francisco under Mary F. Dallman, Ph.D.

info@shockbiotech.com

1100 Wicomico Street

Baltimore, MD 21230

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Facebook Social Icon

© 2020 Shock Therapeutics Biotechnologies, Inc.

Proudly Founded & Headquartered in Baltimore, Maryland